Crofelemer
Small Molecule
Overview
Crofelemer is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2108184).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Crofelemer expires 31 Oct 2031. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.